Consumption of pomegranates improves synaptic function in a transgenic mice model of Alzheimer's disease

Nady Braidy; Musthafa Mohamed Essa; Anne Poljak; Subash Selvaraju; Samir Al-Adawi; Thamilarasan Manivasagm; Arokiasamy Justin Thenmozhi; Lezanne Ooi; Perminder Sachdev; Gilles J. Guillemin

doi:10.18632/oncotarget.10905

Consumption of pomegranates improves synaptic function in a transgenic mice model of Alzheimer's disease

Nady Braidy, Musthafa Mohamed Essa, Anne Poljak, Subash Selvaraju, Samir Al-Adawi, Thamilarasan Manivasagm, Arokiasamy Justin Thenmozhi, Lezanne Ooi, Perminder Sachdev, Gilles J. Guillemin^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

50 Citations (Scopus)

71 Downloads (Pure)

Abstract

Alzheimer's Disease (AD) is a progressive neurodegenerative disorder characterized by extracellular plaques containing abnormal Amyloid Beta (Aβ) aggregates, intracellular neurofibrillary tangles containing hyperphosphorylated tau protein, microglia-dominated neuroinflammation, and impairments in synaptic plasticity underlying cognitive deficits. Therapeutic strategies for the treatment of AD are currently limited. In this study, we investigated the effects of dietary supplementation of 4% pomegranate extract to a standard chow diet on neuroinflammation, and synaptic plasticity in APPsw/Tg2576 mice brain. Treatment with a custom mixed diet (pellets) containing 4% pomegranate for 15 months ameliorated the loss of synaptic structure proteins, namely PSD-95, Munc18-1, and SNAP25, synaptophysin, phosphorylation of Calcium/Calmodulin Dependent Protein Kinase IIα (p-CaMKIIα/CaMKIIα), and phosphorylation of Cyclic AMP-Response Element Binding Protein (pCREB/CREB), inhibited neuroinflammatory activity, and enhanced autophagy, and activation of the phophoinositide-3-kinase-Akt-mammalian target of rapamycin signaling pathway. These neuroprotective effects were associated with reduced β-site cleavage of Amyloid Precursor Protein in APPsw/Tg2576 mice. Therefore, long-term supplementation with pomegranates can attenuate AD pathology by reducing inflammation, and altering APP-dependent processes.

Original language	English
Pages (from-to)	64589-64604
Number of pages	16
Journal	Oncotarget
Volume	7
Issue number	40
DOIs	https://doi.org/10.18632/oncotarget.10905
Publication status	Published - 2016

Bibliographical note

Copyright the Author(s) 2016. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

Keywords

pomegranates
synapse
inflammation
amyloid beta protein
amyloid precursor protein
Gerotarget

Access to Document

10.18632/oncotarget.10905

Publisher version (open access).pdfFinal published version, 2.09 MB

Cite this

@article{364a1f8c7fae4e3d817ea9df6d165c38,

title = "Consumption of pomegranates improves synaptic function in a transgenic mice model of Alzheimer's disease",

abstract = "Alzheimer's Disease (AD) is a progressive neurodegenerative disorder characterized by extracellular plaques containing abnormal Amyloid Beta (Aβ) aggregates, intracellular neurofibrillary tangles containing hyperphosphorylated tau protein, microglia-dominated neuroinflammation, and impairments in synaptic plasticity underlying cognitive deficits. Therapeutic strategies for the treatment of AD are currently limited. In this study, we investigated the effects of dietary supplementation of 4% pomegranate extract to a standard chow diet on neuroinflammation, and synaptic plasticity in APPsw/Tg2576 mice brain. Treatment with a custom mixed diet (pellets) containing 4% pomegranate for 15 months ameliorated the loss of synaptic structure proteins, namely PSD-95, Munc18-1, and SNAP25, synaptophysin, phosphorylation of Calcium/Calmodulin Dependent Protein Kinase IIα (p-CaMKIIα/CaMKIIα), and phosphorylation of Cyclic AMP-Response Element Binding Protein (pCREB/CREB), inhibited neuroinflammatory activity, and enhanced autophagy, and activation of the phophoinositide-3-kinase-Akt-mammalian target of rapamycin signaling pathway. These neuroprotective effects were associated with reduced β-site cleavage of Amyloid Precursor Protein in APPsw/Tg2576 mice. Therefore, long-term supplementation with pomegranates can attenuate AD pathology by reducing inflammation, and altering APP-dependent processes.",

keywords = "pomegranates, synapse, inflammation, amyloid beta protein, amyloid precursor protein, Gerotarget",

author = "Nady Braidy and Essa, {Musthafa Mohamed} and Anne Poljak and Subash Selvaraju and Samir Al-Adawi and Thamilarasan Manivasagm and Thenmozhi, {Arokiasamy Justin} and Lezanne Ooi and Perminder Sachdev and Guillemin, {Gilles J.}",

note = "Copyright the Author(s) 2016. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.",

year = "2016",

doi = "10.18632/oncotarget.10905",

language = "English",

volume = "7",

pages = "64589--64604",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals",

number = "40",

}

TY - JOUR

T1 - Consumption of pomegranates improves synaptic function in a transgenic mice model of Alzheimer's disease

AU - Braidy, Nady

AU - Essa, Musthafa Mohamed

AU - Poljak, Anne

AU - Selvaraju, Subash

AU - Al-Adawi, Samir

AU - Manivasagm, Thamilarasan

AU - Thenmozhi, Arokiasamy Justin

AU - Ooi, Lezanne

AU - Sachdev, Perminder

AU - Guillemin, Gilles J.

N1 - Copyright the Author(s) 2016. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

PY - 2016

Y1 - 2016

N2 - Alzheimer's Disease (AD) is a progressive neurodegenerative disorder characterized by extracellular plaques containing abnormal Amyloid Beta (Aβ) aggregates, intracellular neurofibrillary tangles containing hyperphosphorylated tau protein, microglia-dominated neuroinflammation, and impairments in synaptic plasticity underlying cognitive deficits. Therapeutic strategies for the treatment of AD are currently limited. In this study, we investigated the effects of dietary supplementation of 4% pomegranate extract to a standard chow diet on neuroinflammation, and synaptic plasticity in APPsw/Tg2576 mice brain. Treatment with a custom mixed diet (pellets) containing 4% pomegranate for 15 months ameliorated the loss of synaptic structure proteins, namely PSD-95, Munc18-1, and SNAP25, synaptophysin, phosphorylation of Calcium/Calmodulin Dependent Protein Kinase IIα (p-CaMKIIα/CaMKIIα), and phosphorylation of Cyclic AMP-Response Element Binding Protein (pCREB/CREB), inhibited neuroinflammatory activity, and enhanced autophagy, and activation of the phophoinositide-3-kinase-Akt-mammalian target of rapamycin signaling pathway. These neuroprotective effects were associated with reduced β-site cleavage of Amyloid Precursor Protein in APPsw/Tg2576 mice. Therefore, long-term supplementation with pomegranates can attenuate AD pathology by reducing inflammation, and altering APP-dependent processes.

AB - Alzheimer's Disease (AD) is a progressive neurodegenerative disorder characterized by extracellular plaques containing abnormal Amyloid Beta (Aβ) aggregates, intracellular neurofibrillary tangles containing hyperphosphorylated tau protein, microglia-dominated neuroinflammation, and impairments in synaptic plasticity underlying cognitive deficits. Therapeutic strategies for the treatment of AD are currently limited. In this study, we investigated the effects of dietary supplementation of 4% pomegranate extract to a standard chow diet on neuroinflammation, and synaptic plasticity in APPsw/Tg2576 mice brain. Treatment with a custom mixed diet (pellets) containing 4% pomegranate for 15 months ameliorated the loss of synaptic structure proteins, namely PSD-95, Munc18-1, and SNAP25, synaptophysin, phosphorylation of Calcium/Calmodulin Dependent Protein Kinase IIα (p-CaMKIIα/CaMKIIα), and phosphorylation of Cyclic AMP-Response Element Binding Protein (pCREB/CREB), inhibited neuroinflammatory activity, and enhanced autophagy, and activation of the phophoinositide-3-kinase-Akt-mammalian target of rapamycin signaling pathway. These neuroprotective effects were associated with reduced β-site cleavage of Amyloid Precursor Protein in APPsw/Tg2576 mice. Therefore, long-term supplementation with pomegranates can attenuate AD pathology by reducing inflammation, and altering APP-dependent processes.

KW - pomegranates

KW - synapse

KW - inflammation

KW - amyloid beta protein

KW - amyloid precursor protein

KW - Gerotarget

UR - http://www.scopus.com/inward/record.url?scp=84994097012&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.10905

DO - 10.18632/oncotarget.10905

M3 - Article

C2 - 27486879

AN - SCOPUS:84994097012

SN - 1949-2553

VL - 7

SP - 64589

EP - 64604

JO - Oncotarget

JF - Oncotarget

IS - 40

ER -

Consumption of pomegranates improves synaptic function in a transgenic mice model of Alzheimer's disease

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this